Drug Profile
Hepatitis B vaccine recombinant - AstraZeneca
Latest Information Update: 04 Apr 2022
Price :
$50
*
At a glance
- Originator MedImmune
- Developer MedImmune; sanofi pasteur
- Class DNA vaccines; Hepatitis B vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 26 May 1995 Discontinued-Preclinical for Hepatitis B in USA (IM)